4//SEC Filing
GOLDBERG Y. PAUL 4
Accession 0001171843-17-006255
CIK 0001582313other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 6:45 PM ET
Size
5.3 KB
Accession
0001171843-17-006255
Insider Transaction Report
Form 4
GOLDBERG Y. PAUL
VP of Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2017-10-23+11,000→ 11,000 totalExercise: $3.10Exp: 2027-10-22→ Common Shares (11,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on October 23, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001619960
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 6:45 PM ET
- Size
- 5.3 KB